Effects of angiotensin receptor blockade on serial P-wave signal-averaged electrocardiograms after electrical cardioversion of persistent atrial fibrillation

Europace

Volumn 11, Issue 10, 2009, Pages 1301-1307

  Hegbom, Finn ^a   Tveit, Arnljot ^b   Grundvold, Irene ^a   Arnesen, Harald ^a   Smith, Pal ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b VESTRE VIKEN HOSPITAL TRUST   (Norway)

Author keywords

Angiotensin blocker; Atrial fibrillation; Cardioversion; P SAECG

Indexed keywords

ANGIOTENSIN RECEPTOR; CANDESARTAN; PLACEBO;

ADULT; AGED; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC POTENTIAL; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; P WAVE; PRIORITY JOURNAL; RECURRENT DISEASE; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; SINUS RHYTHM;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; CARDIAC PACING, ARTIFICIAL; DIAGNOSIS, COMPUTER-ASSISTED; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; SIGNAL PROCESSING, COMPUTER-ASSISTED; TETRAZOLES; TREATMENT OUTCOME;

EID: 70349512042     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup220     Document Type: Article

References (24)

1. Larsen MT, Lyngborg K, Pedersen F, Corell P. Predictive factors of maintenance of sinus rhythm after direct current (DC) cardioversion of atrial fibrillation/atrial flutter. Ugeskr Laeger 2005;167:3408-3412
2. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92: 1954-1968
3. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996;94:2968-2974
4. Raitt MH, Kusumoto W, Giraud GD, McAnulty JH. Electrophysiologic predictors of the recurrence of persistent atrial fibrillation within 30 days of cardioversion. Am J Cardiol 2004;93:107-110
5. Manios EG, Kanoupakis EM, Chlouverakis GI, Kaleboubas MD, Mavrakis HE, Vardas PE. Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: relation with recurrence. Cardiovasc Res 2000;47: 244-253
6. Raitt MH, Kusumoto W, Giraud G, McAnulty JH. Reversal of electrical remodeling after cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol 2004; 15 :507-512
7. Dixen U, Joens C, Parner J, Rasmussen V, Pehrson SM, Jensen GB. Prolonged signal-averaged P wave duration after elective cardioversion increases the risk of recurrent atrial fibrillation. Scand Cardiovasc J 2004;38:147-151
8. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angio-tensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005;45:1832-1839
9. Tveit A, Grundvold I, Olufsen M, Seljeflot I, Abdelnoor M, Arnesen H et al. Can-desartan in the prevention of relapsing atrial fibrillation. Int J Cardiol 2007;120: 85-91.
10. Aytemir K, Aksoyek S, Yildirir A, Ozer N, Oto A. Prediction of atrial fibrillation recurrence after cardioversion by P wave signal-averaged electrocardiography. Int J Cardiol 1999;70:15-21.
11. Budeus M, Hennersdorf M, Perings C, Wieneke H, Erbel R, Sack S. Prediction of the recurrence of atrial fibrillation after successful cardioversion with P wave signal-averaged ECG. Ann Noninvasive Electrocardiol 2005;10:414-419
12. Budeus M, Wieneke H, Sack S, Erbel R, Perings C. Long-term outcome after cardioversion of atrial fibrillation: prediction of recurrence with P wave signal averaged ECG and chemoreflexsensitivity. Int J Cardiol 2006;112:308-315 (Pubitemid 44415059)
13. Ehrlich JR, Schadow K, Steul K, Zhang GQ, Israel CW, Hohnloser SH. Prediction of early recurrence of atrial fibrillation after external cardioversion by means of P wave signal-averaged electrocardiogram. Z Kardiol 2003;92:540-546
14. Guo XH, Gallagher MM, Poloniecki J, Yi G, Camm AJ. Prognostic significance of serial P wave signal-averaged electrocardiograms following external electrical car-dioversion for persistent atrial fibrillation: a prospective study. Pacing Clin Electro-physiol 2003;26:299-304.
15. Opolski G, Scislo P, Stanislawska J, Gorecki A, Steckiewicz R, Torbicki A. Detection of patients at risk for recurrence of atrial fibrillation after successful electrical cardioversion by signal-averaged P-wave ECG. Int J Cardiol 1997;60:181-185
16. Raitt MH, Ingram KD, Thurman SM. Signal-averaged P wave duration predicts early recurrence of atrial fibrillation after cardioversion. Pacing Clin Electrophysiol 2000;23:259-265
17. Stafford PJ, Robinson D, Vincent R. Optimal analysis of the signal averaged P wave in patients with paroxysmal atrial fibrillation. Br Heart J 1995;74:413-418
18. Zaman AG, Kearney MT, Schecter C, Worthley SG, Nolan J. Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation. Am Heart J 2004;147:823-827
19. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 2000;101: 2612-2617
20. Kumagai K, Nakashima H, Urata H, Gondo N, Arakawa K, Saku K. Effects of angio-tensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol 2003;41:2197-2204
21. Madrid AH, Marin IM, Cervantes CE, Morell EB, Estévez JE, Moreno G et al. Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers. J Renin Angiotensin Aldosterone Syst 2004;5:114-120
22. Madrid AH, Bueno MG, Rebollo JM, Marín I, Peña G, Bernal E et al. Use of irbe-sartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibril-lation: a prospective and randomized study. Circulation 2002;106:331-336
23. Ueng KC, Tsai TP, Yu WC, Tsai CF, Lin MC, Chan KC et al. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. Eur Heart J 2003;24:2090-2098
24. Disertori M, Latini R, Barlera S, Franzosi MG, Staszewsky L, Maggioni AP et al., The GISSI-AF Investigators. Valsartan for prevention of recurrent atrial fibrillation. N Engl J Med 2009;360:1606-1617